Back
EHRA Premium Access

Comparison of ostial versus very wide antral circumferential pulmonary vein isolation using pulsed field ablation

Session: ePosters Day 2
Topic: Rhythm Control, Catheter Ablation
Speaker: Professor R. Tilz (Luebeck, DE)
Event: EHRA 2022

Presentation

0

About the speaker

Professor Roland Tilz

University Heart Center, Luebeck (Germany)
11 presentations
0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Access
Abstract
Slides
0
Thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Access
Abstract
Slides
0
Thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Access
Abstract
Slides
0
Thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Access
Abstract
Slides
0
Thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access
Abstract
Slides
0
Thumbnail

Access the full session

ePosters Day 2

Speakers: Professor R. Tilz, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...
Access
0
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

Related content

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Atrial high-rate episodes in patients with devices without a history of atrial fibrillation

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

This platform is supported by

logo Novo Nordisk